Navigation Links
Mylan Reports a 23% Increase in Fourth Quarter 2012 Adjusted Diluted EPS to $0.65
Date:2/27/2013

nings increased $40.3 million or 17.8% to $266.9 million for the three months ended December 31, 2012 as compared to adjusted earnings of $226.6 million for the prior year comparable period.

EBITDA, which is defined as net income (excluding the non-controlling interest and income from equity method investees) plus income taxes, interest expense, depreciation and amortization, was $398.5 million for the quarter ended December 31, 2012, and $334.0 million for the comparable prior year period.  After adjusting for certain items as further detailed below, adjusted EBITDA was $462.4 million for the current three-month period and $406.6 million for the comparable prior year period. 

Year Ended December 31, 2012For the year ended December 31, 2012, Mylan reported total revenues of $6.80 billion compared to $6.13 billion in the comparable prior year period. Third party net revenues for the year ended December 31, 2012 were $6.75 billion compared to $6.11 billion for the comparable prior year period, representing an increase of $644.0 million, or 10.5%. Revenues were unfavorably impacted by the effect of foreign currency translation, generally reflecting a stronger U.S. Dollar as compared to the currencies in other major markets in which Mylan operates. Translating third party net revenues at prior year exchange rates would have resulted in year over year increase in third party net revenues, excluding foreign currency, of $840 million, or approximately 14%.

Generics third party net revenues were $5.95 billion for the year ended December 31, 2012, compared to $5.56 billion in the comparable prior year period, representing an increase of $391.2 million, or 7.0%, or an increase of approximately 11% when excluding the unfavorable effect of foreign currency translation.

Third party net revenues from North America were $3.26 billion for the year ended December 31, 2012, compared to $2.86 billion for the comparable prior year period, re
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Mylan Launches Innovative Portfolio of Antiretroviral Products for Treatment of HIV/AIDS in South Africa
2. Mylan Enhances Partnership with Biocon through Strategic Collaboration for Insulin Products
3. Mylan Schedules Fourth Quarter and Year End 2012 Financial Results Conference Call and Live Webcast
4. Mylan Appoints Melina Higgins and Rajiv Malik to Board of Directors
5. Mylan Announces Pricing of Senior Notes
6. Moodys and Standard & Poors Upgrade Mylan to Investment Grade Credit Ratings
7. Mylan Reports a 51% Increase in Third Quarter 2012 Adjusted Diluted EPS to $0.83
8. Mylan Selected as a Leading ARV Supplier to Indias National AIDS Control Organization
9. Pfizer and Mylan Team Up to Establish Exclusive Long-Term Strategic Collaboration to Drive Sustained Growth of Generics Business in Japan
10. Mylan Launches Lithium Carbonate Extended-Release Tablets USP
11. Mylan Launches Commercial Operations in India, Starting with a Broad, Innovative Portfolio of ARV Products to Treat HIV/AIDS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... MANCHESTER, England , July 22, 2014 ... AEX:PHIA) announced today that The Christie NHS Foundation Trust ... center, will join a consortium whose mission is to ... imaging (MRI) guided radiation therapy system. Such a system ... real-time visualization of cancer targets. "The ...
(Date:7/22/2014)... 22, 2014  Halozyme Therapeutics, Inc. (NASDAQ: ... and dosing of patients in its ongoing Phase 2 ... cancer under the revised clinical protocol agreed to with ... form of Halozyme,s proprietary recombinant human hyaluronidase under development ... "Our diligent effort to rapidly re-initiate ...
(Date:7/22/2014)... Fla. , July 22, 2014  Neurotrope Bioscience, ... signed a world-wide, exclusive license agreement with the Icahn ... ( Mount Sinai ) to utilize ... of Bryostatin-1 in the treatment of Niemann-Pick Type C ... are afflicted with Alzheimer-like symptoms. The license also covers ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... OKLAHOMA CITY, Jan. 6, 2011 Altheus Therapeutics, Inc., ... active-controlled Phase I clinical trial of the safety and ... left-sided, or distal, ulcerative colitis.  No serious adverse events ... excited to have achieved this milestone, as it prepares ...
... Calif., Jan. 6, 2011 Viveve, Inc. , ... it has received the European CE (Conformite Europeenne) mark ... non-surgical treatment of laxity of the vaginal introitus (opening), ... (Logo:   http://photos.prnewswire.com/prnh/20110106/SF25673LOGO ) "The CE mark ...
Cached Medicine Technology:Altheus Therapeutics Completes Phase I Clinical Study of Zoenasa™ in Ulcerative Colitis 2Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity 2
(Date:7/22/2014)... July 22, 2014 Dr. Jeremy K. ... surgical colleagues, have recently discussed the reasons for an ... in the periodontics profession are seeing the amount of ... exponentially. In fact, one surgeon reported that over 50% ... Although dental implants have a very high success rate ...
(Date:7/22/2014)... 2014 A Florida woman has filed ... alleges the death of her husband was the result ... Bernstein Liebhard LLP reports. According to her complaint, which ... the Southern District of Florida on June 23rd, the ... a subdural hemorrhage the following June. Despite emergency treatment, ...
(Date:7/22/2014)... Society of Hematology (ASH) will honor Michael DeBaun, MD, ... P. Hebbel, MD, of the University of Minnesota Medical ... for their significant research advances in the area of ... for the late Ernest Beutler, MD, a past president ... is a two-part lectureship that recognizes major translational advances ...
(Date:7/22/2014)... says women are often in the dark. Historically, it was ... has shown that post-menopausal women are just as likely as ... be adequately diagnosed and treated. New research from Western University ... Clinical Pharmacology brings to light a genetic basis for ... are more prone to heart disease. , The study, led ...
(Date:7/22/2014)... 22, 2014 SIMpalm, a ... payment app for Forte Payment System. Forte Mobile Payment ... payments on iPhone, iPod and iPad. The app ... recently updated by SIMpalm. This update was for iOS ... supported on iOS 4.3 and is available to download ...
Breaking Medicine News(10 mins):Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 2Health News:Dr. Jeremy Ueno Can Help Treat Patients That Have Failing Implants 3Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit Filed by Florida Woman Alleges Uncontrollable Bleeding Led to Husband’s Death, Bernstein Liebhard LLP Reports 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 2Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 3Health News:Michael DeBaun, M.D., M.P.H., and Robert P. Hebbel, M.D., to present 2014 ASH Beutler Lecture 4Health News:Gene variant identified as a heart disease risk factor for women 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 2Health News:SIMpalm Launched Updated Forte Mobile Payment App on iPhone and iPad for Its Client 3
... payment models that reward workers for meeting certain performance ... P4P programs use a variety of methods to reward ... bonuses. A new study in the ... appear to be effective in incentivizing low performing physicians. ...
... Government of ... the NGO Tostan to end the practice by 2015 , ... Dakar, Senegal (PRWEB) February 19, 2010 -- Building on a ... of communities in Senegal join its ranks in recent years, the Government of Senegal will ...
... , ... ... , , , ... ...
... ... recently launched a robust health encyclopedia offering health news and feature articles on vitamins, ... , ... (PRWEB) February 19, 2010 -- eVitamins™, a leading online retailer of vitamins, supplements and ...
... teaching health benefits, study finds , FRIDAY, Feb. 19 ... to exercise is to focus on the fun of ... "Our study shows that for inactive teenagers, emphasizing the ... way to encourage exercise than highlighting traditional health benefits," ...
... ... ... ... ...
Cached Medicine News:Health News:Senegal: Total End of Female Genital Cutting Now in Sight 2Health News:Registered Nurses from Public Health - Seattle & King County Hold Informational Picket to Highlight Public Safety Concerns 2Health News:Registered Nurses from Public Health - Seattle & King County Hold Informational Picket to Highlight Public Safety Concerns 3Health News:eVitamins Launches New Health Encyclopedia 2Health News:Teens Might Exercise More If They Think It's Fun 2Health News:MDS Announces Substantial Issuer Bid 2Health News:MDS Announces Substantial Issuer Bid 3Health News:MDS Announces Substantial Issuer Bid 4Health News:MDS Announces Substantial Issuer Bid 5Health News:MDS Announces Substantial Issuer Bid 6
... The Answer to Micro-Incision Cataract ... Technology With its unique double-step ... knife is ideal for MICS. ... reproducible incisions that allow you ...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Subretinal Injection Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Medicine Products: